Se Hee Park

Se Hee Park

Auto-generated profile, based on publicly available information

Se Hee Park

Division of Endocrinology and Metabolism, Department of Internal Medicine, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
YLYongseop Lee
Yongseop Lee
SASangmin Ahn
Sangmin Ahn
MHMin Han
Min Han
JLJung Ah Lee
Jung Ah Lee
JAJin Young Ahn
Jin Young Ahn
JKJung Ho Kim
Jung Ho Kim

8 December 2020 in Frontiers in Plant Science
Verified
Journal Article
Open access
PDF file
HKHyun Min Kim
Hyun Min Kim
SPSe Hee Park
Se Hee Park
SMSang Hoon Ma
Sang Hoon Ma
SPSeo Young Park
Seo Young Park
CYChul-Ho Yun
Chul-Ho Yun
YJYoung Hee Joung
Young Hee Joung
Abscisic acid (ABA) is a key signaling molecule that mediates plant response to stress. Increasing evidence indicates that ABA also regulates many aspects of plant development, such as seed germination, leaf development, and ripening. ABA metabolism, including ABA biosynthesis and degradation, is an essential aspect of ABA response in plants. In this study, we identified four cytochrome P450 genes (CaCYP707A1,2,3, and4) that mediate ABA hydroxylation, which is required for ABA degradation inCapsicum annuum. We observed that CaCYP707A-mediated ABA hydroxylation promotes ABA degradation, leading to low levels of ABA and a dehydration phenotype in35S:CaCYP707Aplants. Importantly, seed formation was strongly inhibited in35S:CaCYP707Aplants, and a cross-pollination test suggested that the defect in seed formation is caused by improper pollen development. Phenotypic analysis showed that pollen maturation is suppressed in35S:CaCYP707A1plants. Consequently, most35S:CaCYP707A1pollen grains degenerated, unlike non-transgenic (NT) pollen, which developed into mature pollen grains. Together our results indicate that CaCYP707A mediates ABA hydroxylation and thereby influences pollen development, helping to elucidate the mechanism underlying ABA-regulated pollen development.

1 August 2016 in Medicine
Verified
Journal Article
Open access
SPSe Hee Park
Se Hee Park
JNJoo Young Nam
Joo Young Nam
EHEugene Han
Eugene Han
YLYong-ho Lee
Yong-ho Lee
BLByung Wan Lee
Byung Wan Lee
EKEun Seok Kang
Eun Seok Kang
Hyperglycemia is associated with increased mortality and morbidity in patients with type 2 diabetes mellitus (T2DM) who are undergoing dialysis. Although dipeptidyl peptidase-4 (DPP-4) inhibitors have been widely used in end-stage renal disease (ESRD) patients with T2DM, there are few studies on their efficacy in this population. We studied the effect of 3 different DPP-4 inhibitors on metabolic parameters in ESRD patients with T2DM. Two hundred ESRD patients with T2DM who were treated with DPP-4 inhibitors (sitagliptin, vildagliptin, or linagliptin) were enrolled and analyzed retrospectively. The changes in glycated hemoglobin (HbA1c), fasting plasma glucose, and lipid profiles were assessed before and after 3 months of treatment with DPP-4 inhibitors. Subgroup analysis was done for each hemodialysis (HD) and peritoneal dialysis (PD) group. There was no significant difference in the decrease in the HbA1c level among sitagliptin, vildagliptin, and linagliptin treatment groups (−0.74 ± 1.57, −0.39 ± 1.45, and −0.08 ± 1.40, respectively, P = 0.076). The changes in fasting blood glucose and lipid profiles were also not significantly different. In HD patients (n = 115), there was no difference in the HbA1c level among the 3 groups. In contrast, in PD patients (n = 85), HbA1c was reduced more after 3 months of treatment with sitagliptin compared with vildagliptin and linagliptin (−1.58 ± 0.95, −0.46 ± 0.98, −0.04 ± 1.22, respectively, P = 0.001). There was no significant difference in the glucose-lowering effect between the different DPP-4 inhibitors tested in ESRD patients. In PD patients, sitagliptin tends to lower the HbA1c level more than the other inhibitors. The glucose-lowering efficacy of the 3 DPP-4 inhibitors was comparable.


5 December 2017 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
SPSe Hee Park
Se Hee Park
SHSena Hwang
Sena Hwang
SHSeunghee Han
Seunghee Han
DSDong Yeob Shin
Dong Yeob Shin
ELEunjig Lee
Eunjig Lee
Radioactive iodine (RAI) therapy is an effective treatment option for Graves’ disease. However, predicting treatment failures after RAI therapy remains controversial. The objective of this study was to investigate the factors associated with the success rate of RAI therapy for treatment of Graves’ hyperthyroidism. Thyroid functional outcome, pre-RAI ultrasonographic features, and clinical parameters were evaluated retrospectively in 98 patients followed up for at least 12 months after RAI (mean RAI dose was 11.7 ± 1.8 mCi). Hypothyroidism was achieved in 59 patients (60.2%), and euthyroidism in 16 patients (16.3%), while 23 patients (23.5%) remained hyperthyroid. Age, sex, body mass index, pre-RAI thyroid function, or thyroid-stimulating immunoglobulin levels were not associated with treatment outcome. Length of thyroid isthmus (p=0.028) and 2- to 24-hour iodine uptake ratios (p=0.002) were significantly associated with treatment failure, which was defined as a persistent hyperthyroid status after RAI therapy. Patients with a longer isthmus had a higher risk of remaining hyperthyroid, with a threshold for isthmus length of 5.2 mm, with a sensitivity of 69.6% and specificity of 70.3% for treatment success. Measuring the length of the thyroid isthmus can be a simple and useful way to predict RAI treatment outcome.

1 January 2014 in Scientia Horticulturae
Verified
Journal Article
Open access
SPSe Hee Park
Se Hee Park
GBgianluca burchi
gianluca burchi
MRMark S. Roh
Mark S. Roh
YJYoung Hee Joung
Young Hee Joung